Management of acute myocardial infarction in intensive care units in 1995: A nationwide French survey of practice and early hospital results

Journal of the American College of Cardiology

Volumn 30, Issue 7, 1997, Pages 1598-1605

  Danchin, Nicolas ^a   Vaur, Laurent ^b   Genès, Nathalie ^b   Renault, Maguy ^b   Ferrières, Jean ^c   Etienne, Sylvie ^b   Cambou, Jean Pierre ^c  

^a CHU NANCY BRABOIS   (France)

^b Laboratoires Roussel   (France)

^c Inst Natl par la S e la Rech M   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; NITRATE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; FIBRINOLYTIC THERAPY; FRANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; FEMALE; FRANCE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PATIENT ADMISSION; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031541870     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00371-9     Document Type: Article

References (44)

1. McGovern PG, Pankow JS, Shahar E, et al., for the Minnesota Heart Survey Investigators. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med 1996;334:884-90.
2. Osmond C. Coronary heart disease mortality trends in England and Wales, 1952-1991. J Public Health Med. 17:1995;404-410.
3. Al-Roomi KA, Dobson AJ, Hall E, Heller RF, Magnus P. Declining mortality from ischemic heart disease and cerebrovascular disease in Australia. Am J Epidemiol. 129:1989;503-510.
4. Ueshima H, Tatara K, Asakura S. Declining mortality from ischemic heart disease and changes in coronary risk factors in Japan, 1956-1980. Am J Epidemiol. 125:1987;62-72.
5. Goldbourt U, Neufeld HN. Trends in heart disease mortality and related factors in Israel. Cardiology. 72:1985;63-74.
6. DeWood MA, Spores J, Nottke R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 303:1980;897-902.
7. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1:1986;397-402.
8. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction ISIS 2 . Lancet. 2:1988;349-360.
9. Grines CL, Browne KF, Marco J, et al., for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
10. GISSI-3 effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction . Lancet. 343:1994;1115-1122.
11. A randomized factorial trial assessing early captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected myocardial infarction. Lancet. 345:1995;669-685.
12. Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828.
13. Kober L, Torp-Pedersen C, Carlsen JE, et al., for the Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333:1670-6.
14. Held PH, Yusuf S. Effects of beta-blockers and calcium channel blockers in acute myocardial infarction. Eur Heart J. 14:(Suppl F):1993;18-25.
15. A randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet. 339:1992;753-770.
16. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;383-389.
17. Berning J, Steenegaard-Hansen F. Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. Am J Cardiol. 65:1990;567-576.
18. Fréquence et conditions d'hospitalisation des infarctus récents du myocarde en France. L'enquête nationale ENIM 84. Arch Mal Coeur. 80:1987;1853-1863.
19. Monassier JP, Hanania G, Khalifé K, Frelon JH, Boureux C, Fournier PY. Stratégies thérapeutiques à la phase aiguë de l'infarctus du myocarde résultats du registre STIM 93 . Arch Mal Coeur. 89:1996;281-289.
20. Haas B, Arveiler D, Cambou JP, et al. Prise en charge thérapeutique de l'infarctus du myocarde évolution dans le projet MONICA-France entre 1985 et 1991 . Rev Epidémiol Santé Publ. 44:1996;S53-S61.
21. Gaspoz JM, Unger PF, Urban P, et al. Impact of a public campaign on pre-hospital delay in patients reporting chest pain. Heart. 76:1996;150-155.
22. Boissel JP, Némoz C, Gillet J, Salewski B, Diaz N. La prescription médicamenteuse dans le postinfarctus résultats de l'étude EPPI (étude de prescription postinfarctus): etude coopérative française . Arch Mal Coeur. 83:1990;1777-1782.
23. Boissel JP, Némoz C, Leizorovicz A, Gillet J. La prescription médicamenteuse dans le postinfarctus; résultats de l'EPPI II (étude de prescription postinfarctus) etude coopérative française . Arch Mal Coeur. 88:1995;1261-1266.
24. Translation of clinical trials into practice a European population-based study of the use of thrombolysis for acute myocardial infarction . Lancet. 347:1996;1203-1207.
25. Gheorghiade M, Ruzumna P, Borzak S, Havstad S, Ali A, Goldstein S. Decline in the rate of hospital mortality from acute myocardial infarction impact of changing management strategies . Am Heart J. 131:1996;250-256.
26. Gurwitz JH, Goldberg RJ, Gore JM. Coronary thrombolysis for the elderly? JAMA. 265:1991;1720-1723.
27. White H, Cross D, Scott M, Norris R. Comparison of effects of thrombolytic therapy on left ventricular function in patients over with those under 60 years of age. Am J Cardiol. 67:1991;913-918.
28. Venturini F, Romero M, Tognoni G. Acute myocardial infarction treatments in 58 Italian hospitals a drug utilization survey . Ann Pharmacother. 29:1995;1100-1105.
29. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993) observations from the National Registry of Myocardial Infarction . Circulation. 90:1994;2103-2114.
30. Rouleau JL, Talajic M, Sussex B, et al. Myocardial infarction patients in the 1990s. Their risk factors, stratification and survival in Canada the Canadian Assessment Myocardial Infarction (CAMI) study . J Am Coll Cardiol. 27:1996;1119-1127.
31. Pilote L, Califf RM, Sapp S, et al., for the GUSTO-1 Investigators. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med 1995;333:565-72.
32. A British Cardiac Society survey of the potential for secondary prevention of coronary disease ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Principal results . Heart. 75:1996;334-342.
33. Brand DA, Newcomer LN, Freiburger A, Tian H. Cardiologists' practices compared with practice guidelines use of beta-blockade after acute myocardial infarction . J Am Coll Cardiol. 26:1995;1432-1436.
34. Collins R, Julian D. British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction. Br Heart J. 66:1991;250-255.
35. Graille V, Ferrières J, Marques-Vidal P, Ruidavets JB, Rodier P, Cambou JP. Evolution à long terme de la prescription médicamenteuse chez 174 patients atteints d'infarctus du myocarde suivis pendant 4,5 ans (étude DEVENIR). Arch Mal Coeur. 89:1996;35-39.
36. Maheu B, Mansourati J, Guillo P, Larlet JM, Salaun G, Blanc JJ. Mortalité et morbidité à la phase aiguë de l'infarctus du myocarde comparaison de trois cohortes de patients hospitalisés espacées de 10 ans . Arch Mal Coeur. 89:1996;187-192.
37. Ferrières J, Cambou JP, Ruidavets JB, Pous J. Trends in acute myocardial infarction prognosis and treatment in Southwestern France between 1985 and 1990 (the MONICA project-Toulouse). Am J Cardiol. 75:1995;1202-1205.
38. Dellborg M, Eriksson P, Swedberg K. Declining hospital mortality in acute myocardial infarction. Eur Heart J. 15:1994;5-9.
39. Greenbaum RA, Morris R, Sritara P, Shanit D, Chan KL. Reduced in-hospital mortality from acute myocardial infarction with general adoption of thrombolytic therapy in the North West Thames health region 1979-1991. Br Heart J. 74:1995;493-496.
40. Behar S, Goldbout U, Barbash G, Modan B. Twenty-five year mortality rate decrease in patients in Israel with a first episode of acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial Study Group. Israeli Thrombolytic Survey Group. Am Heart J. 130:1995;453-458.
41. Maynard C, Weaver D, Litwin PE, et al., for the MITI Project Investigators. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention Project). Am J Cardiol 1993;72:877-82.
42. Lee KL, Woodlief LH, Topol EJ, et al., for the Gusto-1 Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 1995;91:1659-68.
43. Indications for fibrinolytic therapy in suspected acute myocardial infarction collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients . Lancet. 343:1994;311-322.
44. Lamas GA, Pfeffer MA, Hamm P, et al. Do the results of clinical trials of cardiovascular drugs influence medical practice? N Engl J Med. 327:1992;241-247.